Atypical antipsychotics for acute agitation - New intramuscular options offer advantages

被引:30
作者
Citrome, L
机构
[1] Nathan S Kline Inst Psychiat Res, Clin Res & Evaluat Facil, Orangeburg, NY 10962 USA
[2] NYU, Sch Med, New York, NY USA
关键词
D O I
10.3810/pgm.2002.12.1369
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
The newer, atypical antipsychotics are better tolerated than the older neuroleptics. The intramuscular formulations of these drugs are useful in behavioral emergencies, when oral dosing is impractical. In addition, they provide a smooth transition to oral dosing with the same agent once the acute agitation has been managed. In this article, Dr Citrome discusses patient assessment, selection of an agent, and future possibilities for improved control.
引用
收藏
页码:85 / +
页数:7
相关论文
共 21 条
[1]
BICK PA, 1986, LANCET, V1, P206
[2]
Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder [J].
Bilder, RM ;
Goldman, RS ;
Volavka, J ;
Czobor, P ;
Hoptman, M ;
Sheitman, B ;
Lindenmayer, JP ;
Citrome, L ;
McEvoy, J ;
Kunz, M ;
Chakos, M ;
Cooper, TB ;
Horowitz, TL ;
Lieberman, JA .
AMERICAN JOURNAL OF PSYCHIATRY, 2002, 159 (06) :1018-1028
[3]
Intramuscular ziprasidone compared with intramuscular haloperidol in the treatment of acute psychosis [J].
Brook, S ;
Lucey, JV ;
Gunn, KP .
JOURNAL OF CLINICAL PSYCHIATRY, 2000, 61 (12) :933-941
[4]
New antipsychotic medications - What advantages do they offer? [J].
Citrome, L .
POSTGRADUATE MEDICINE, 1997, 101 (02) :207-&
[5]
Psychopharmacology of violence .2. Beyond the acute episode [J].
Citrome, L ;
Volavka, J .
PSYCHIATRIC ANNALS, 1997, 27 (10) :696-703
[6]
Violent patients in the emergency setting [J].
Citrome, L ;
Volavka, J .
PSYCHIATRIC CLINICS OF NORTH AMERICA, 1999, 22 (04) :789-+
[7]
DIETCH JT, 1988, J CLIN PSYCHIAT, V49, P184
[8]
*FDA PSYCH DRUGS A, 2001, BRIEF DOC ZIPR MESYL
[9]
*FDA PSYCH DRUGS A, 2001, BRIEF DOC ZYPR INTR
[10]
PHARMACOKINETIC COMPARISON OF SUB-LINGUAL LORAZEPAM WITH INTRAVENOUS, INTRAMUSCULAR, AND ORAL LORAZEPAM [J].
GREENBLATT, DJ ;
DIVOLL, M ;
HARMATZ, JS ;
SHADER, RI .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1982, 71 (02) :248-252